HEADER MEMBRANE PROTEIN 27-AUG-10 2L2T TITLE SOLUTION NMR STRUCTURE OF THE ERBB4 DIMERIC MEMBRANE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MEMBRANE DOMAIN (UNP RESIDUES 642-685); COMPND 5 SYNONYM: PROTO-ONCOGENE-LIKE PROTEIN C-ERBB-4, P180ERBB4, TYROSINE COMPND 6 KINASE-TYPE CELL SURFACE RECEPTOR HER4; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERBB4, HER4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEMEX1 KEYWDS ERBB4, TRANSMEMBRANE DIMER, MEMBRANE DOMAIN, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.S.MINEEV,E.V.BOCHAROV,M.V.GONCHARUK,A.S.ARSENIEV REVDAT 2 06-SEP-17 2L2T 1 JRNL REVDAT 1 14-SEP-11 2L2T 0 JRNL AUTH E.V.BOCHAROV,K.S.MINEEV,M.V.GONCHARUK,A.S.ARSENIEV JRNL TITL STRUCTURAL AND THERMODYNAMIC INSIGHT INTO THE PROCESS OF JRNL TITL 2 "WEAK" DIMERIZATION OF THE ERBB4 TRANSMEMBRANE DOMAIN BY JRNL TITL 3 SOLUTION NMR. JRNL REF BIOCHIM. BIOPHYS. ACTA V.1818 2158 2012 JRNL REFN ISSN 0006-3002 JRNL PMID 22579757 JRNL DOI 10.1016/J.BBAMEM.2012.05.001 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1, CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L2T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000101885. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM [U-98% 15N] PROTEIN, 10 MM REMARK 210 EDTA, 2 MM SODIUM AZIDE, 12 MM REMARK 210 DMPC, 48 MM DHPC, 90% H2O/10% REMARK 210 D2O; 1 MM PROTEIN, 10 MM EDTA, 2 REMARK 210 MM SODIUM AZIDE, 12 MM DMPC, 48 REMARK 210 MM DHPC, 1 MM [U-98% 13C; U-98% REMARK 210 15N] PROTEIN, 90% H2O/10% D2O; 1 REMARK 210 MM PROTEIN, 10 MM EDTA, 2 MM REMARK 210 SODIUM AZIDE, 12 MM DMPC, 48 MM REMARK 210 DHPC, 1 MM [U-98% 13C; U-98% 15N] REMARK 210 PROTEIN, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D HNCA; 3D HN(CO)CA; REMARK 210 2D 1H-1H NOESY; 3D 1H-15N NOESY; REMARK 210 3D HCCH-TOCSY; 3D 1H-13C NOESY; REMARK 210 3D 13C-FILT. NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; UNITY REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.8.3 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 43 -171.48 51.45 REMARK 500 1 PRO A 45 -164.92 -69.72 REMARK 500 1 ARG A 49 -78.09 -68.73 REMARK 500 1 THR A 50 59.06 -164.04 REMARK 500 1 SER A 79 80.47 46.51 REMARK 500 1 THR B 44 -171.19 51.52 REMARK 500 1 PRO B 46 -175.81 -69.69 REMARK 500 1 THR B 51 63.25 -161.72 REMARK 500 1 SER B 80 79.37 46.90 REMARK 500 2 PRO A 45 -164.77 -69.81 REMARK 500 2 GLN A 46 -75.07 -63.48 REMARK 500 2 ARG A 49 -79.81 -63.50 REMARK 500 2 THR A 50 61.14 -163.39 REMARK 500 2 ARG A 84 49.78 -146.15 REMARK 500 2 PRO B 46 -165.14 -69.84 REMARK 500 2 GLN B 47 -75.74 -49.97 REMARK 500 2 ARG B 50 -75.01 -47.12 REMARK 500 2 THR B 51 60.99 -162.41 REMARK 500 2 ARG B 85 49.83 -145.57 REMARK 500 3 PRO A 45 -167.26 -69.75 REMARK 500 3 HIS A 47 84.50 54.86 REMARK 500 3 THR A 50 72.26 -114.07 REMARK 500 3 ILE A 80 57.58 -93.39 REMARK 500 3 LYS A 83 173.98 59.96 REMARK 500 3 PRO B 46 -170.27 -69.79 REMARK 500 3 HIS B 48 84.55 55.05 REMARK 500 3 THR B 51 72.20 -114.19 REMARK 500 3 ILE B 81 57.64 -93.27 REMARK 500 3 LYS B 84 174.00 60.12 REMARK 500 4 THR A 43 -171.00 51.41 REMARK 500 4 PRO A 45 -167.25 -69.76 REMARK 500 4 HIS A 47 90.05 -167.07 REMARK 500 4 THR A 50 73.74 -113.62 REMARK 500 4 SER A 79 71.23 46.36 REMARK 500 4 ILE A 80 53.81 -93.30 REMARK 500 4 LYS A 82 -169.76 -163.27 REMARK 500 4 LYS A 83 92.57 63.16 REMARK 500 4 ARG A 84 -42.50 -146.12 REMARK 500 4 THR B 44 -170.99 51.38 REMARK 500 4 PRO B 46 -170.36 -69.70 REMARK 500 4 HIS B 48 90.16 -166.84 REMARK 500 4 THR B 51 73.90 -113.61 REMARK 500 4 SER B 80 71.73 46.31 REMARK 500 4 ILE B 81 53.61 -92.95 REMARK 500 4 LYS B 83 -169.92 -163.58 REMARK 500 4 LYS B 84 92.54 63.28 REMARK 500 4 ARG B 85 -42.62 -146.15 REMARK 500 5 PRO A 45 -167.40 -69.81 REMARK 500 5 HIS A 47 103.52 63.01 REMARK 500 5 ALA A 48 116.44 -161.37 REMARK 500 REMARK 500 THIS ENTRY HAS 186 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7205 RELATED DB: BMRB REMARK 900 ASSIGNMENT OF CHEMICAL SHIFTS DBREF 2L2T A 42 85 UNP Q15303 ERBB4_HUMAN 642 685 DBREF 2L2T B 43 86 UNP Q15303 ERBB4_HUMAN 642 685 SEQRES 1 A 44 SER THR LEU PRO GLN HIS ALA ARG THR PRO LEU ILE ALA SEQRES 2 A 44 ALA GLY VAL ILE GLY GLY LEU PHE ILE LEU VAL ILE VAL SEQRES 3 A 44 GLY LEU THR PHE ALA VAL TYR VAL ARG ARG LYS SER ILE SEQRES 4 A 44 LYS LYS LYS ARG ALA SEQRES 1 B 44 SER THR LEU PRO GLN HIS ALA ARG THR PRO LEU ILE ALA SEQRES 2 B 44 ALA GLY VAL ILE GLY GLY LEU PHE ILE LEU VAL ILE VAL SEQRES 3 B 44 GLY LEU THR PHE ALA VAL TYR VAL ARG ARG LYS SER ILE SEQRES 4 B 44 LYS LYS LYS ARG ALA HELIX 1 1 THR A 50 ARG A 77 1 28 HELIX 2 2 THR B 51 ARG B 78 1 28 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1